Concerns over weakening demand for Indian pharmaceutical (pharma) drugs in the US - their largest export market - have weighed heavily on investor sentiment this year.
While the Nifty 50 has gained 6.02 per cent year - to - date (as on September 15), the Nifty Pharma index has declined 5.18 per cent, National Stock Exchange data shows.
Uploaded by:
Rediff Video Desk
on Tue, 16 Sep 2025 13:50:11 +0530
Views: 19
Tags: Pharma stocks slide as US headwinds hurt